Skip to main content
SpringerLink
Log in

Testicular Tumors

  • Chapter
Cancer in Adolescents and Young Adults

Part of the book series: Pediatric Oncology ((PEDIATRICO))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bleyer WA, OLeary M, Barr R, Ries LAG (eds) (2006) Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, including SEER Incidence and Survival, 1975–2000. National Cancer Institute, NIH Pub. No. 06-5767, Bethesda MD, June 2006; also available at www.seer.cancer.gov/publications

    Google Scholar 

  2. Ries LAG, Eisner MP, Kosary CL, et al (2002) SEER cancer statistics review, 1973–1999. National Cancer Institute, Bethesda, MD

    Google Scholar 

  3. Chaganti RS, Rodriguez E, Bosl GJ (1993) Cytogenetics of male germ cell tumors. Urol Clin North Am 20:55–66

    PubMed  CAS  Google Scholar 

  4. Bussey KJ, Lawce HJ, Olsen SB, et al (1999) Chromosome abnormalities of 81 pediatric germ cell tumors: Sex-, age-, site-, and histopathology-related differences: a Children’s Cancer Group study. Genes Chromosomes Cancer 25:134–146

    Article  PubMed  CAS  Google Scholar 

  5. Cullen JW, Olson TA, Giller R, et al (2002) Low dose bleomycin every three weeks with cisplatin and etoposide results in excellent EFS and survival rates for children and adolescents with gonadal germ cell tumors (MGCT): a POG/CCG intergroup report. In: Harden P, Joffe JK, Jones WG (eds) Germ Cell Tumors V. Springer-Verlag, London

    Google Scholar 

  6. Cushing B, Giller R, Cullen JW, et al (2004) Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study — Pediatric Oncology Group 9049 and Children’s Cancer Group 8882. J Clin Oncol 22:2691–2700

    Article  PubMed  CAS  Google Scholar 

  7. Rogers PC, Olson TA, Cullen JW, et al (2004) Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: a pediatric intergroup study — Pediatric Oncology Group 9048 and Children Cancer Group 8891. J Clin Oncol 22:3563–3569

    Article  PubMed  Google Scholar 

  8. Green FL, Balch CM, Page DL, et al (eds) (2002) American Joint Commission on Cancer (AJCC) Cancer Staging Manual (6th edn). Springer-Verlag, New York, pp 77–87

    Google Scholar 

  9. International Germ Cell Cancer Collaborative Group (1997) International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15:594–603

    Google Scholar 

  10. Daugaard G, Rorth M (2003) Active surveillance for stage I nonseminomatous germ cell tumors. In: Raghavan D (ed) American Cancer Society Atlas of Clinical Oncology: Germ Cell Tumors. Decker, London, p 132

    Google Scholar 

  11. Freedman LS, Parkinson MC, Jones WG, et al (1987) Histopathology in the prediction of relapse in patients with stage I testicular teratoma treated by orchidectomy alone. Lancet 2:294–298

    Article  PubMed  CAS  Google Scholar 

  12. Schlatter M, Resorla F, Giller R, et al (2003) Excellent outcome in patients with stage I germ cell tumors of the testes: a study of the Children’s Cancer Group/Pediatric Oncology Group. J Pediatric Surg 38:319–324

    Article  Google Scholar 

  13. Rorth M, Jacobsen GK, von der Maase H, et al (1991) Surveillance alone versus radiotherapy after orchidectomy for clinical stage I nonseminomatous testicular cancer. J Clin Oncol 9:1543–1548

    PubMed  CAS  Google Scholar 

  14. Toner GC, Stockler MR, Boyer MJ, et al (2001) Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomized trial of the Australian and New Zealand Germ Cell Trial Group. Lancet 357: 739–745

    Article  PubMed  CAS  Google Scholar 

  15. de Wit R, Roberts JT, Wilkinson PM, et al (2001) Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3-or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council. J Clin Oncol 19:1629–1640

    PubMed  Google Scholar 

  16. Culine S, Kerbrat P, Bouzy J, et al (1999) Are 3 cycles of bleomycin, etoposide, and cisplatin (3BEP) or 4 cycles of etoposide and cisplatin (4EP) equivalent regimens for patients with good-risk metastatic non seminomatous germ cell tumours? Preliminary results of a randomized trial. Proc Am Soc Clin Oncol 18:A1188

    Google Scholar 

  17. van Leeuwen F, Stigglebout A, Canden Belt-Dusebout A (1993) Second cancer risk following testicular cancer: a follow-up study of 1909 patients. J Clin Oncol 11:415–424

    PubMed  Google Scholar 

  18. Wanderas EH, Fossa SD, Tretli S (1997) Risk of subsequent non-germ-cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients. J Clin Oncol 11:253–259

    Google Scholar 

  19. Arranz Arija JA, Garcia del Muro X, Guma J, et al (2001) E400P in advanced seminoma of good prognosis according to the International Germ Cell Cancer Collaborative Group (IGCCCG) classification: the Spanish Germ Cell Cancer Group experience. Ann Oncol 12:487–491

    Article  PubMed  CAS  Google Scholar 

  20. Horwich A, Oliver RTD, Wilkinson PM, et al (2000) A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. Br J Cancer 83:1623–1629

    Article  PubMed  CAS  Google Scholar 

  21. Gritz ER, Wellisch DK, Wang HJ, et al (1989) Longterm effects of testicular cancer on sexual functioning in married couples. Cancer 64:1560–1567

    Article  PubMed  CAS  Google Scholar 

  22. Gritz ER, Wellisch DK, Landsverk JA (1988) Psychosocial sequelae in long-term survivors of testicular cancer. J Psychosoc Oncol 6:41–63

    Article  Google Scholar 

  23. Joly F, Heron JF, Kalusinski L, et al (2002) Quality of life in long-term survivors of testicular cancer: a population-based case-control study. J Clin Oncol 20:73–80

    Article  PubMed  CAS  Google Scholar 

  24. Rieker PP, Edbril SD, Garnick MB (1985) Curative testis cancer therapy: psychosocial sequelae. J Clin Oncol 3:1117–1126

    PubMed  CAS  Google Scholar 

  25. de Wit R, Stoter G, Kaye SB, et al (1997) Importance of bleomycin in combination chemotherapy for goodprognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group. J Clin Oncol 15:1837–1843

    PubMed  Google Scholar 

  26. Boyer MJ, Raghavan D, Harris PJ, et al (1990) Lack of late toxicity in patients treated with cisplatin-containing combination chemotherapy for metastatic testicular cancer. J Clin Oncol 8:21–26

    PubMed  CAS  Google Scholar 

  27. Hansen SW, Olsen N (1989) Raynaud’s phenomenon in patients treated with cisplatin, vinblastine, and bleomycin fpr germ cell cancer: measurement of vasoconstrictor response to cold. J Clin Oncol 7:940–942

    PubMed  CAS  Google Scholar 

  28. Pedersen-Bjergaard J, Philip P, Larsen SO, et al (1993) Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia 7:1975–1986

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Children’s Hematology-Oncology Associates, Denver, Co, 80210, USA

    John W. Cullen M.D.

  2. Dept. of Hermatology/Oncology, University of Indiana, 702 Barnhill Dr., Indianapolis, IN, 46202, USA

    Robert Fallon M.D., Ph.D.

Authors
  1. John W. Cullen M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert Fallon M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. St. Charles Medical Center, Bend, Oregon, USA

    W. Archie Bleyer

  2. McMaster University, Hamilton, Ontario, Canada

    Ronald D. Barr

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Cullen, J.W., Fallon, R. (2007). Testicular Tumors. In: Bleyer, W.A., Barr, R.D. (eds) Cancer in Adolescents and Young Adults. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68152-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-68152-6_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-40842-0

  • Online ISBN: 978-3-540-68152-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation